Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab

Abroad (travel likely)RecruitingPHASE1

Conditions

Hepatocellular Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of California, San Diego, San Diego, California, United States
Contact: Study coordinator (Adam Burgoyne, MD, PhD) · CancerCTO@health.ucsd.edu · 858-822-5354

Study leads

Adam Burgoyne, MD, PhD
Principal Investigator
University of California, San Diego

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

Metastatic Hepatocellular Carcinoma · Local Advanced Hepatocellular Carcinoma · Alpha-fetoprotein (AFP)-Producing Gastric Cancer

Abroad (travel likely)RecruitingPHASE1

Goodyear, United States · Duarte, United States

SBRT With Atezo/Bev for HCC

Hepatocellular Carcinoma

Abroad (travel likely)RecruitingPHASE1

Philadelphia, United States

A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients

Advanced Hepatocellular Carcinoma

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China

Single Centre Prospective Evaluation of 68Gallium-FAPI PET/MRI in Hepatocellular Carcinoma

Hepatocellular Carcinoma

Abroad (travel likely)RecruitingPHASE1

Singapore, Singapore